Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Pozzilli

Showing results (31-40 of 247) with videos related to

Pageof 25
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 3, 2018
Predicting the profile of increasing disability in multiple sclerosisValentina Tomassini, Fulvia Fanelli, Luca Prosperini, et al.
Journal of the Neurological Sciences|January 18, 2014
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: results from a longitudinal studyFrancesco Patti, Angelo Pappalardo, Enrico Montanari, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 10, 2021
Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple SclerosisLuca Prosperini, Serena Ruggieri, Shalom Haggiag, et al.
Expert Review of Neurotherapeutics|May 17, 2019
Advances in preventing adverse events during monoclonal antibody management of multiple sclerosisLaura De Giglio, Alessandro E Grimaldi, Federica Fubelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 12, 2010
The use of ID migraine™ questionnaire in patients with multiple sclerosisVeronica Villani, Luca Prosperini, Carlo Pozzilli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2010
Visuo-proprioceptive training reduces risk of falls in patients with multiple sclerosisLuca Prosperini, Laura Leonardi, Paolo De Carli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 3, 2014
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosisLuca Prosperini, Floriana De Angelis, Rosanna De Angelis, et al.
Therapeutic Advances in Neurological Disorders|May 2, 2019
Advances in spinal cord imaging in multiple sclerosisMarcello Moccia, Serena Ruggieri, Antonio Ianniello, et al.
BMC Neurology|March 1, 2011
Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective?Luca Prosperini, Giovanna Borriello, Laura De Giglio, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 3, 2017
Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective studyPamela Latino, Letizia Castelli, Luca Prosperini, et al.
Pageof 25

Showing results (31-40 of 247) with videos related to

Sort By:
Pageof 25
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 3, 2018
Predicting the profile of increasing disability in multiple sclerosisValentina Tomassini, Fulvia Fanelli, Luca Prosperini, et al.
Journal of the Neurological Sciences|January 18, 2014
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: results from a longitudinal studyFrancesco Patti, Angelo Pappalardo, Enrico Montanari, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 10, 2021
Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple SclerosisLuca Prosperini, Serena Ruggieri, Shalom Haggiag, et al.
Expert Review of Neurotherapeutics|May 17, 2019
Advances in preventing adverse events during monoclonal antibody management of multiple sclerosisLaura De Giglio, Alessandro E Grimaldi, Federica Fubelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 12, 2010
The use of ID migraine™ questionnaire in patients with multiple sclerosisVeronica Villani, Luca Prosperini, Carlo Pozzilli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2010
Visuo-proprioceptive training reduces risk of falls in patients with multiple sclerosisLuca Prosperini, Laura Leonardi, Paolo De Carli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 3, 2014
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosisLuca Prosperini, Floriana De Angelis, Rosanna De Angelis, et al.
Therapeutic Advances in Neurological Disorders|May 2, 2019
Advances in spinal cord imaging in multiple sclerosisMarcello Moccia, Serena Ruggieri, Antonio Ianniello, et al.
BMC Neurology|March 1, 2011
Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective?Luca Prosperini, Giovanna Borriello, Laura De Giglio, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 3, 2017
Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective studyPamela Latino, Letizia Castelli, Luca Prosperini, et al.
Pageof 25